News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
News
Business
RNAi Delivery Company Cequent Pharmaceuticals, Inc. Raises $6 Million Series A
November 30, 2006
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
Cequent Pharmaceutials Inc., an RNA interference delivery start-up, has raised $6 million in a Series A financing round that could grow to a total of $12 million, the company told VentureWire.
>>>
Discuss This Story
Twitter
LinkedIn
Facebook
Email
Print
Startups
MORE ON THIS TOPIC
Rare diseases
JPM Day 3: Rare Disease in the Spotlight
January 15, 2026
·
5 min read
·
Tristan Manalac
Insights
JPM26: As Capital Concentrates, VCs Scrutinize Founder Pedigree and CEO Fit in Early Biotech
January 15, 2026
·
2 min read
·
Jennifer Smith-Parker
Opinion
Trump Must Make Biotech Innovation a National Priority
January 14, 2026
·
7 min read
·
Cyriac Roeding
Business
JPM26: Novo Refocuses on Diabetes and Obesity Amid Push To Expand GLP-1 Market
January 14, 2026
·
3 min read
·
Nick Paul Taylor